Fusion status in patients with lymph node-positive (N1) alveolar rhabdomyosarcoma is a powerful predictor of prognosis: Experience of the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG)

on behalf of the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG)

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Fusion status in patients with lymph node-positive (N1) alveolar rhabdomyosarcoma is a powerful predictor of prognosis: Experience of the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG)'. Together they form a unique fingerprint.

Medicine & Life Sciences